Oura Ring Lawsuit: Can a Smart Ring Really Track Your Sleep?

A lawsuit filed against Oura, the company behind the popular smart ring, claims the company misled customers by saying its ring can accurately track sleep stages when, according to the complaint, the device is right only about half the time.

The complaint, Surber v. Oura Inc. et al. (case number 26-cv-08686), was filed by Clarkson Law Firm on behalf of a customer named Madison Surber, who bought an Oura Ring 4 Gold around May 22, 2025. News of the filing was widely reported on August 21, 2026, with additional coverage from The Verge's Optimizer newsletter and ClassAction.org through August 26 (Mashable, The Verge, ClassAction.org).

The dispute comes down to a basic limitation of wearable devices like smart rings and watches: they cannot directly measure brain activity. Sleep stages are defined by distinct brain-wave patterns, and the lawsuit argues that because a smart ring lacks the sensors to read brain waves, it cannot accurately track those stages. Instead, Oura uses AI models that guess your sleep stages from indirect signals like heart rate, body temperature, and movement. The complaint says the company takes advantage of "desperate consumers who struggle with their sleep" by selling this guesswork as reliable science (The Verge).

The gap between what Oura advertised and what the ring actually does is the heart of the case. Oura marketed its ring as measuring different sleep stages with 95% accuracy. Attorney Shireen Clarkson of Clarkson Law Firm stated that Oura's own internal estimates put sleep-stage accuracy closer to 50%. The complaint cites independent scientific studies showing roughly the same figure, which the lawsuit likens to a "coin flip" (USA Today, The Verge, ClassAction.org).

Oura has pushed back. The company published a rebuttal linking to peer-reviewed validation studies for its sleep tracking algorithm, along with a supportive op-ed from a sleep researcher. Oura's response frames its methodology as scientifically grounded and independently verified (The Verge).

The broader context here is the gap between how consumer health gadgets are marketed and how they actually work. In a clinical sleep study, doctors use sensors that directly measure brain waves, eye movement, and muscle activity to determine sleep stages. Consumer wearables cannot do this. Instead, they use light sensors to measure blood flow, motion detectors, and temperature readings, then feed all of that into a machine-learning model that guesses which sleep stage you are in. The result is an educated guess, not a direct measurement. When a wearable claims 95% accuracy, that number usually reflects how well it matched clinical results in a controlled lab study, not how reliably it works on its own in someone's bedroom.

The lawsuit's framing of AI-based guessing as inherently suspect is worth flagging. All consumer wearables use this kind of inference to produce sleep-stage estimates. The real question is not whether they use inference but whether their accuracy claims are backed up and honestly communicated. The difference between a device that matches clinical results 95% of the time in a lab and one that gets it right only 50% of the time in real life is the difference between a useful tool and an expensive random number generator. Whether Oura's devices are one or the other, and whether its marketing crossed the line from optimistic to deceptive, is what the court will weigh.

What remains genuinely useful about consumer sleep wearables, even at less-than-clinical accuracy, is trend tracking. A device that is only 50% accurate at labeling a given night's sleep stages may still capture meaningful shifts over time in total sleep, resting heart rate, and nighttime movement. The risk, though, is that when people see specific sleep-stage labels presented with false precision, they may make health decisions based on data that is, in the lawsuit's words, a coin flip. That is the core issue the court will be asked to resolve.